Diagnostics & Research · Healthcare
COO
2026-03-01–present
Equibles does not estimate personal net worth.
Get an email with a short summary when Thermo Fisher Scientific Inc. publishes a filing, an earnings call transcript or a press release.
Get TMO alertsGianluca Pettiti is recorded as COO at Thermo Fisher Scientific Inc. (TMO) since March 1, 2026. Earlier roles on record: Board Member at Butterfly Network, Inc. (BFLY) until December 22, 2023. Thermo Fisher Scientific Inc. reported in an 8-K filed January 12, 2026 that Gianluca Pettiti was appointed President and Chief Operating Officer, effective March 1, 2026. Butterfly Network, Inc. reported in an 8-K filed December 22, 2023 that Gianluca Pettiti resigned as member of the Board of Directors. The proxy statement of Thermo Fisher Scientific Inc. reports total compensation of $8,080,467 for Gianluca Pettiti in fiscal 2025, including a base salary of $1,031,918. Disclosed compensation is on record for 5 fiscal years. Thermo Fisher Scientific Inc. is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at Thermo Fisher Scientific Inc. includes Marc Casper (CEO), Marc N. Casper (CEO and Board Member), James R. Meyer (CFO) and 7 others.
“Gianluca Pettiti, currently an Executive Vice President, will be promoted and transition to the role of President and Chief Operating Officer.”
“On December 20, 2023, Gianluca Pettiti, a member of the Board of Directors (the "Board") of Butterfly Network, Inc. (the "Company"), notified the Company of his resignation from the Board, including the Audit Committee of the Board (the "Audit Committee"), on which he serves as a member, and the Compensation Committee of the Board (the "Compensation Committee"), on which he serves as the Chair, effective as of the date the Board appoints his replacements on the Audit Committee and Compensation Committee.”
2026-03-01–present
Proxy statement
Start not stated–present
Last confirmed April 8, 2025
Start not stated–2023-12-22
Diagnostics & Research · Healthcare
COO
2026-03-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Thermo Fisher Scientific Inc. (TMO) | Executive Vice President | $1,031,918 | $8,080,467 |
| 2024 | Thermo Fisher Scientific Inc. (TMO) | Executive Vice President | $956,558 | $11,340,424 |
| 2023 | Thermo Fisher Scientific Inc. (TMO) | Executive Vice President | $868,836 | $5,731,883 |
| 2022 | Thermo Fisher Scientific Inc. (TMO) | Executive Vice President | $768,630 | $5,740,707 |
| 2021 | Thermo Fisher Scientific Inc. (TMO) | Executive Vice President | $611,647 | $6,605,884 |